Professional-grade financial intelligence

20M+ securities. Real-time data. Institutional insights.

Subscribe for $2

Trusted by professionals at Goldman Sachs, BlackRock, and JPMorgan

Overview
Profile
Meridian Bioscience Stock

Meridian Bioscience Stock VIVO

VIVO
US5895841014
871583

Price

33.97
Today +/-
+0
Today %
+0 %

Meridian Bioscience stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Meridian Bioscience stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Meridian Bioscience stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Meridian Bioscience stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Meridian Bioscience's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Meridian Bioscience Stock Price History

DateMeridian Bioscience Price
1/31/202333.97 undefined
1/30/202333.97 undefined

Meridian Bioscience Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Meridian Bioscience, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Meridian Bioscience from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Meridian Bioscience’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Meridian Bioscience. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Meridian Bioscience’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Meridian Bioscience’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Meridian Bioscience’s growth potential.

Meridian Bioscience Revenue, EBIT and net profit per share

DateMeridian Bioscience RevenueMeridian Bioscience EBITMeridian Bioscience Net Income
2025e300.53 M undefined22.86 M undefined18.78 M undefined
2024e302.36 M undefined32.45 M undefined26.22 M undefined
2023e294.11 M undefined46.97 M undefined37.34 M undefined
2022333.02 M undefined75.6 M undefined42.46 M undefined
2021317.9 M undefined101.83 M undefined71.41 M undefined
2020253.7 M undefined68 M undefined46.2 M undefined
2019201 M undefined38.9 M undefined24.4 M undefined
2018213.6 M undefined44.7 M undefined23.8 M undefined
2017200.8 M undefined44.8 M undefined21.6 M undefined
2016196.1 M undefined53.6 M undefined32.2 M undefined
2015194.8 M undefined56.1 M undefined35.5 M undefined
2014188.8 M undefined52.4 M undefined34.7 M undefined
2013188.7 M undefined57.3 M undefined38 M undefined
2012172.7 M undefined50.3 M undefined33.4 M undefined
2011158.8 M undefined41.8 M undefined26.8 M undefined
2010143 M undefined41.1 M undefined26.6 M undefined
2009148.3 M undefined48.8 M undefined32.8 M undefined
2008139.6 M undefined44.4 M undefined30.2 M undefined
2007123 M undefined35 M undefined26.7 M undefined
2006108.4 M undefined26.9 M undefined18.3 M undefined
200593 M undefined20.3 M undefined12.6 M undefined
200479.6 M undefined14.7 M undefined9.2 M undefined
200365.9 M undefined12.8 M undefined7 M undefined

Meridian Bioscience Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)
REVENUE GROWTH (%)
GROSS MARGIN (%)
GROSS INCOME (M)
NET INCOME (M)
NET INCOME GROWTH (%)
SHARES (M)
DOCUMENTS
1984198519861987198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023e2024e2025e
2465568111416212529353353575659657993108123139148143158172188188194196200213201253317333294302300
-100.0050.00-16.67-20.0033.3337.5027.2714.2931.2519.0516.0020.69-5.7160.617.55-1.755.3610.1721.5417.7216.1313.8913.016.47-3.3810.498.869.30-3.191.032.046.50-5.6325.8725.305.05-11.712.72-0.66
50.0075.0066.6760.0060.0050.0062.5063.6464.2968.7566.6768.0068.9762.8666.6764.1561.4046.4357.6358.4656.9658.0659.2660.1661.8762.1661.5462.0363.3764.3662.2362.3764.8062.0061.5058.7161.6663.4156.4663.9562.2562.67
13433357911141720222234352634384554647486928898109121117121127124131118156201188000
01100001112356527-10579121826303226263338343532212324467142372618
----------100.0050.0066.6720.00-16.67-60.00250.00-242.86-150.0040.0028.5733.3350.0044.4415.386.67-18.75-26.9215.15-10.532.94-8.57-34.389.524.3591.6754.35-40.85-11.90-29.73-30.77
23.523.824.727.127.127.127.127.327.527.628.232.733.23333.132.83332.833.233.634.336.240.240.74141.141.141.441.641.941.94242.442.642.842.943.244.0144.38000
------------------------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Meridian Bioscience Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Meridian Bioscience is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETS
CASH BALANCE (M)
RECEIVABLES (M)
OTHER REC. (M)
INVENTORIES (M)
OTHER CURRENT LIAB. (M)
CURRENT ASSETS (M)
TANGIBLE ASSETS (M)
LONG-T. INVEST. (M)
LONG-T. REC. (M)
INTANGIBLE ASSETS (M)
GOODWILL (M)
OTHER NON-CURRENT ASSETS (M)
NON-CURRENT ASSETS (M)
TOTAL ASSETS (M)
LIABILITIES
COMMON STOCK (M)
ADDITIONAL PAID-IN CAPITAL (M)
RETAINED EARNINGS (M)
OTHER EQUITY (k)
UNREAL. GAINS/LOSSES (M)
EQUITY (M)
LIABILITIES (M)
PROVISIONS (M)
OTHER SHORT-TERM LIAB. (M)
SHORT-TERM DEBTS (M)
LONG-TERM DEBT PORTION (M)
SHORT-TERM REC. (M)
LONG-T. LIAB. (M)
DEFERRED TAXES (M)
OTHER LIAB. (M)
LONG-T. LIABILITIES (M)
DEBT (M)
TOTAL CAPITAL (M)
19851986198719881989199019911992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022
                                                                           
0.75.94.93.64.22.71.61.89.58.88.919.721.723.87.24.84.73.12.1233.140.349.449.361.337.923.631.644.3435047.257.159.862.453.549.7781.45
0.60.80.80.90.91.31.62.53.55.26.59.210.69.712.513.912.512.614.917.917.419.622.725.12722.124.824.226.223.226.327.129.132.335.638.553.5747.24
0.100000000000000.44.90000000000000000000000
0.20.40.40.60.91.51.82.32.7334.34.75.610.415.812.112.714.114.116.81718.219.923.328.432.731.734.835.535.845.141.54239.661.376.8467.81
0.10.20.10.10.20.20.30.40.40.40.60.60.80.71.31.33.121.52.233.83.55.15.579.29.18.7117.47.46.257.18.912.6314.1
1.77.36.25.26.25.75.3716.117.41933.837.839.831.840.732.430.432.636.270.380.793.899.4117.195.490.396.6114112.7119.5126.8133.9139.1144.7162.2192.81210.6
0.81.72.52.92.62.42.94.64.25.47.18.48.58.814.217.516.71817.617.317.517.818.319.720.521.226.526.226.127.627.530.530.53030.637.54950.71
0.500000000000000000000007.500000000000000
000000000000.60.30.90.91.60.30.20.10.10.200000000000000000
00000000004.88.67.16201812.811.410.29.313.210.89.58.87.313.310.910.38.17.85.929.926.723.160.283.284.1574.13
0000000008.83.11.71.71.74.4634.555.48.89.9109.99.923.323.123.123.123.222.36254.954.689.2114.2114.67116.3
0.10.10.50.80.62.52.82.560.70.51.6220.90.80.70.5110.81.31.21.21.21.54.55.25.45.68.133.84.60.78.29.111.36
1.41.833.73.24.95.77.110.214.915.520.919.619.440.443.933.534.633.933.140.539.83947.138.959.36564.862.764.263.8125.4115.9112.3180.7243.1256.92252.5
3.19.19.28.99.410.61114.126.332.334.554.757.459.272.284.665.96566.569.3110.8120.5132.8146.5156154.7155.3161.4176.7176.9183.3252.2249.8251.4325.4405.3449.72463.1
                                                                           
00.50.50.50.50.50.60.911.21.52.42.42.42.42.52.52.52.50000000000000000000
03.93.93.93.93.947.69.410.813.920.520.620.720.920.92121.221.625.971.67582.289.191.794.5100102.4107.4111.9117.2122.4125.6129.2132.8140.2147.4155.66
1.62.93.43.63.94.652.31.51.43.76.810.111.911.114.90.91.93.97.312.719.530.43945.542.238.140.246.948.951.149.646.949.663.1109.3180.7223.16
00000000-300-200-300-200-400-300-800-1,700-1,400-1,200-600-300-500-100400400700700400100700300-2,300-5,500-2,900-3,400-5,000-1,900198-10,504
00000000000000000000000000000000000000
1.67.37.888.399.610.811.613.218.829.532.734.733.636.62324.427.432.983.894.4113128.5137.9137.4138.5142.7155161.1166166.5169.6175.4190.9247.6328.3368.32
0.20.10.40.20.30.30.30.30.81.80.710.81.13.53.32.41.92.32.62.93.74.74.86.94.55.55.85.656.67.67.76.37.21211.717.76
0.20.30.30.20.20.50.60.80.91.31.72.52.12.64.95.45.25.27.59.511.711.911.510.49.198.911.1137.97.79.77.312.311.723.830.9725.72
0.60.50.10.10.20.40.30.40.10.90.50.81.20000.84.24.23.94.65.10.80.90.71.10.81.610.90.91.53.30.3216.74.4914.48
000000000000004.46.25.92.90.50000000000000000000
00.10.10.10.1000.40.60.40.40.10.20.20.81.72.10.90.90.70.600000000003.84.55.30000
110.90.60.81.21.21.92.44.43.34.44.33.913.616.616.415.115.416.719.820.71716.116.714.615.218.519.613.815.222.622.824.220.952.547.1657.95
00.30.30.20.10.10.11.412.314.712.420.720.620.621.427.224.323.621.517.12.71.800000000054.650.144.975.868.86025
000000000000003.64.32.31.82.12.64.33.82.71.91.32.81.70.200034.53.82.53.81.060.58
0.50.30.30.20.20.20.10.10.100000000000000000002.12.22.25.42.73.135.332.513.2111.51
0.50.60.60.40.30.30.21.512.414.712.420.720.620.62531.526.625.423.619.775.62.71.91.32.81.70.22.12.22.26357.351.8113.6105.174.2637.09
1.51.61.511.11.51.43.414.819.115.725.124.924.538.648.14340.53936.426.826.319.7181817.416.918.721.71617.485.680.176134.5157.6121.4295.04
3.18.99.399.410.51114.226.432.334.554.657.659.272.284.76664.966.469.3110.6120.7132.7146.5155.9154.8155.4161.4176.7177.1183.4252.1249.7251.4325.4405.2449.72463.36
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Meridian Bioscience provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Meridian Bioscience's financial health and stability.

Assets

Meridian Bioscience's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Meridian Bioscience must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Meridian Bioscience after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Meridian Bioscience's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)
DEPRECIATION (M)
DEFERRED TAXES (k)
CHANGES IN WORKING CAPITAL (M)
NON-CASH ITEM (M)
PAID INTEREST (M)
PAID TAXES (M)
NET CASH FLOW FROM OPERATING ACTIVITIES (M)
CAPITAL EXPENDITURES (M)
CASH FLOW FROM INVESTING ACTIVITIES (M)
CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)
INTEREST INCOME AND EXPENSES (M)
NET DEBT CHANGE (M)
NET CHANGE IN EQUITY (M)
CASH FLOW FROM FINANCING ACTIVITIES (M)
CASH FLOW FROM OTHER FINANCING ACTIVITIES ()
TOTAL DIVIDENDS PAID (M)
NET CHANGE IN CASH FLOW (M)
FREE CASH FLOW (M)
SHARE-BASED COMPENSATION (M)
19851986198719881989199019911992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022
1100000112355427-10579121826303226263338343532212324467142
00000000112232544334454444555556879131516
0000000000000000-4,00001,0000000000-1,000-1,000-1,0000001,000000-3,000-1,000
0000000-100-2-2-200-7420-11-2-5-7-5-3-111-1-7-2-600-1-10-197
0000000000000010130000101113345441043-2316
00000000000011122211000000000000111210
0100000011233344-40137612151716171620192017126792726
00000001242466958111212182226293229224244384237413436476682
0-1-1-10-2-1-2-3-4-2-6-1-1-2-4-1-3-1-2-2-3-3-5-3-3-9-4-3-7-4-4-4-4-3-3-18-8
00-1-10-2-1-2-4-4-2-2115-17-9-1-4-3-3-9-80-13-3-16-9-4-3-7-3-66-4-4-48-54-40-11
00000000000-1526-15-500-10-7-53-70-1300001-6200-44-51-22-2
00000000000000000000000000000000000000
0000000110001500-16-3-5-5-5-3000000000058-3-425-7-8-35
040000000000000000013312410302122000332
0400000090013-2-3-43-7-9-9-922-10-13-16-24-29-27-30-28-31-3027-27-2714-3-31-34
----------------------------------2.00---25.00-1.00
0000000000-1-2-2-3-2-3-3-4-4-5-7-11-15-21-26-29-30-31-31-32-33-33-24-21-10000
050-10-1-10700-348-13-10-1003131304-16-14712-16-2921-8-331
-0.3-0.18-0.92-1.230.64-1.45-0.57-0.73-1.890.10.39-1.894.835.326.841.156.787.8710.59.9915.5918.9223.1224.5528.7426.5313.3137.6141.1631.2638.0533.2236.8930.5832.3844.6848.5573.75
00000000000000000000000000000000000000

Meridian Bioscience stock margins

The Meridian Bioscience margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Meridian Bioscience. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Meridian Bioscience.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Meridian Bioscience's sales revenue. A higher gross margin percentage indicates that the Meridian Bioscience retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Meridian Bioscience's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Meridian Bioscience's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Meridian Bioscience's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Meridian Bioscience. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Meridian Bioscience's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Meridian Bioscience Margin History

Meridian Bioscience Gross marginMeridian Bioscience Profit marginMeridian Bioscience EBIT marginMeridian Bioscience Profit margin
2025e56.56 %7.61 %6.25 %
2024e56.56 %10.73 %8.67 %
2023e56.56 %15.97 %12.7 %
202256.56 %22.7 %12.75 %
202163.27 %32.03 %22.46 %
202061.57 %26.8 %18.21 %
201959.05 %19.35 %12.14 %
201861.33 %20.93 %11.14 %
201761.9 %22.31 %10.76 %
201664.86 %27.33 %16.42 %
201562.58 %28.8 %18.22 %
201462.08 %27.75 %18.38 %
201364.12 %30.37 %20.14 %
201263.12 %29.13 %19.34 %
201161.96 %26.32 %16.88 %
201062.03 %28.74 %18.6 %
200962.31 %32.91 %22.12 %
200861.96 %31.81 %21.63 %
200760.89 %28.46 %21.71 %
200659.69 %24.82 %16.88 %
200559.03 %21.83 %13.55 %
200457.41 %18.47 %11.56 %
200358.12 %19.42 %10.62 %

Meridian Bioscience Stock Sales Revenue, EBIT, Earnings per Share

The Meridian Bioscience earnings per share therefore indicates how much revenue Meridian Bioscience has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Meridian Bioscience earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Meridian Bioscience's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Meridian Bioscience’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Meridian Bioscience's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Meridian Bioscience Revenue, EBIT and net profit per share

DateMeridian Bioscience Sales per ShareMeridian Bioscience EBIT per shareMeridian Bioscience Earnings per Share
2025e6.77 undefined0 undefined0.42 undefined
2024e6.81 undefined0 undefined0.59 undefined
2023e6.63 undefined0 undefined0.84 undefined
20227.5 undefined1.7 undefined0.96 undefined
20217.22 undefined2.31 undefined1.62 undefined
20205.87 undefined1.57 undefined1.07 undefined
20194.69 undefined0.91 undefined0.57 undefined
20184.99 undefined1.04 undefined0.56 undefined
20174.71 undefined1.05 undefined0.51 undefined
20164.63 undefined1.26 undefined0.76 undefined
20154.64 undefined1.34 undefined0.85 undefined
20144.51 undefined1.25 undefined0.83 undefined
20134.5 undefined1.37 undefined0.91 undefined
20124.15 undefined1.21 undefined0.8 undefined
20113.84 undefined1.01 undefined0.65 undefined
20103.48 undefined1 undefined0.65 undefined
20093.61 undefined1.19 undefined0.8 undefined
20083.4 undefined1.08 undefined0.74 undefined
20073.02 undefined0.86 undefined0.66 undefined
20062.7 undefined0.67 undefined0.46 undefined
20052.57 undefined0.56 undefined0.35 undefined
20042.32 undefined0.43 undefined0.27 undefined
20031.96 undefined0.38 undefined0.21 undefined

Meridian Bioscience business model

Meridian Bioscience Inc. is a global company specializing in the development, manufacture, and distribution of test kits for the diagnosis of infectious diseases and other medical conditions. The company was founded in 1976 by William J. Motto and initially focused on the development of enzyme immunoassays (EIA). Over the years, the company has grown and diversified its product offerings, becoming a leading provider of diagnostic test kits for acute and chronic medical conditions, infectious diseases, gastrointestinal infections, and virology. The company's success is attributed to its diverse range of test kits in various medical areas, including immunology, infectious diseases, sexually transmitted diseases, gastroenterology, and virology. Additionally, Meridian Bioscience Inc. stays up-to-date with the latest technological advancements in biotechnology to ensure the fast and effective performance of its tests. The company operates globally, collaborating with universities, research institutions, government agencies, and distributors to ensure the worldwide distribution and marketing of its products. In summary, Meridian Bioscience Inc. is an innovative company specializing in the development, manufacture, and distribution of test kits for the diagnosis of infectious diseases and other medical conditions. Its wide range of products, including immunology products, infectious disease diagnostics, sexually transmitted disease test kits, gastroenterology, virology, and molecular diagnostics, coupled with advanced technologies, provides fast, accurate, and reliable diagnostic support. Meridian Bioscience is one of the most popular companies on Eulerpool.com.

Meridian Bioscience SWOT Analysis

Strengths

Meridian Bioscience Inc has a strong reputation in the healthcare industry, particularly in the field of diagnostics and testing kits. The company's advanced technology and extensive product portfolio give it a competitive edge.

Meridian Bioscience Inc has a solid financial position with stable revenues and profits. Its strong financial standing allows the company to invest in research and development, innovate its product offerings, and expand its market presence.

Weaknesses

Despite its strong reputation and financial position, Meridian Bioscience Inc faces certain weaknesses. The company relies heavily on a few key customers for a significant portion of its revenue, which creates a dependency and increases the risk of revenue fluctuations.

Another weakness is the limited geographical presence of Meridian Bioscience Inc. The company primarily operates within the United States, which restricts its market reach and exposes it to potential risks associated with regional economic downturns or regulatory changes.

Opportunities

The increasing global demand for diagnostics and healthcare products presents significant opportunities for Meridian Bioscience Inc. The company can expand its market presence by entering new geographical regions and tapping into emerging markets with a growing need for healthcare solutions.

Furthermore, advancements in technology and the ongoing COVID-19 pandemic have accelerated the importance of rapid testing and diagnostics. Meridian Bioscience Inc can leverage these opportunities to develop and market innovative solutions that address the evolving healthcare landscape.

Threats

Meridian Bioscience Inc faces competition from other established players in the healthcare industry. The presence of larger competitors with greater resources and market presence poses a threat to the company's market share and growth prospects.

Additionally, regulatory challenges and changing government policies can create uncertainties for Meridian Bioscience Inc. Compliance with evolving regulations and adherence to quality standards require continuous monitoring and can impact the company's operations and profitability.

Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Meridian Bioscience Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Meridian Bioscience historical P/E ratio, EBIT multiple, and P/S ratio

Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Meridian Bioscience shares outstanding

The number of shares was Meridian Bioscience in 2024 — This indicates how many shares 44.375 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Meridian Bioscience earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Meridian Bioscience's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Meridian Bioscience’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Meridian Bioscience's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Meridian Bioscience stock splits

In Meridian Bioscience's history, there have been no stock splits.

Meridian Bioscience dividend history and estimates

In 2024, Meridian Bioscience paid a dividend amounting to 0.34 USD. Dividend means that Meridian Bioscience distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Meridian Bioscience provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Meridian Bioscience’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Meridian Bioscience's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Meridian Bioscience Dividend History

DateMeridian Bioscience Dividend
2025e0.24 undefined
2024e0.34 undefined
2023e0.51 undefined
20190.13 undefined
20180.5 undefined
20170.5 undefined
20160.8 undefined
20150.8 undefined
20140.8 undefined
20130.76 undefined
20120.95 undefined
20110.76 undefined
20100.76 undefined
20090.68 undefined
20080.56 undefined
20070.43 undefined
20060.31 undefined
20050.21 undefined
20040.18 undefined
20030.16 undefined

Meridian Bioscience dividend payout ratio

In 2024, Meridian Bioscience had a payout ratio of 57.65%. The payout ratio indicates the percentage of the company's profits that Meridian Bioscience distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Meridian Bioscience represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Meridian Bioscience could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Meridian Bioscience's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Meridian Bioscience Payout Ratio History

DateMeridian Bioscience Payout ratio
2025e56.51 %
2024e57.65 %
2023e60.81 %
202251.09 %
202161.04 %
202070.29 %
201921.93 %
201890.91 %
201798.04 %
2016105.26 %
201594.12 %
201496.39 %
201383.52 %
2012118.75 %
2011116.92 %
2010116.92 %
200985 %
200875.68 %
200765.66 %
200666.67 %
200560.95 %
200465.84 %
200376.19 %
Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Meridian Bioscience.

Meridian Bioscience latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
9/30/20220.15 0.21  (37.25 %)2022 Q4
6/30/20220.16 0.16  (-1.96 %)2022 Q3
3/31/20220.48 0.66  (36.22 %)2022 Q2
12/31/20210.26 0.35  (37.25 %)2022 Q1
9/30/20210.21 0.24  (14.78 %)2021 Q4
6/30/20210.31 0.22  (-29.67 %)2021 Q3
3/31/20210.49 0.57  (17.24 %)2021 Q2
12/31/20200.43 0.65  (52.94 %)2021 Q1
9/30/20200.14 0.1  (-28.26 %)2020 Q4
6/30/20200.24 0.55  (131.09 %)2020 Q3
1
2
3
4
5
...
10

Meridian Bioscience shareholders

%
Name
Stocks
Change
Date
15.21430 % BlackRock Institutional Trust Company, N.A.6,751,3448,8109/30/2022
11.08761 % The Vanguard Group, Inc.4,920,12524,1989/30/2022
4.96770 % Magnetar Capital Partners LP2,204,41831,1241/9/2023
4.42927 % Renaissance Technologies LLC1,965,487-66,2779/30/2022
4.30630 % Impactive Capital LP1,910,919-973,57110/28/2022
4.06338 % Dimensional Fund Advisors, L.P.1,803,127-130,9649/30/2022
3.66446 % State Street Global Advisors (US)1,626,1051089/30/2022
2.72422 % AllianceBernstein L.P.1,208,8731,045,5169/30/2022
1.97356 % Geode Capital Management, L.L.C.875,76914,5329/30/2022
1.93747 % Goldman Sachs & Company, Inc.859,753748,6619/30/2022
1
2
3
4
5
...
10

Meridian Bioscience Executives and Management Board

Mr. John Kenny

(54)
Meridian Bioscience Chief Executive Officer, Director (since 2017)
Compensation 4.6 M

Dr. Lourdes Weltzien

(57)
Meridian Bioscience Executive Vice President - Life Science
Compensation 1.23 M

Mr. Tony Serafini - Lamanna

(59)
Meridian Bioscience Executive Vice President - Diagnostics
Compensation 1.2 M

Mr. Andrew Kitzmiller

(43)
Meridian Bioscience Chief Financial Officer, Executive Vice President, Director (since 2022)
Compensation 882,896

Ms. Julie Smith

(54)
Meridian Bioscience Senior Vice President, Principal Accounting Officer, Controller
Compensation 786,416
1
2

Meridian Bioscience Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Bruker Stock
Bruker
SupplierCustomer0,950,91-0,25-0,78-0,740,09
DiaSorin SpA Stock
DiaSorin SpA
SupplierCustomer-0,110,760,50-0,78-0,77-0,47
Eiken Chemical Stock
Eiken Chemical
SupplierCustomer-0,710,28-0,14-0,86-0,68-0,26
1

Most common questions regarding Meridian Bioscience

What values and corporate philosophy does Meridian Bioscience represent?

Meridian Bioscience Inc represents a strong set of values and corporate philosophy. The company is committed to quality and innovation in the field of biotechnology. They strive to provide accurate and reliable diagnostic solutions to improve patient care. Meridian Bioscience Inc also prioritizes integrity and ethical conduct in all aspects of their business operations. With a focus on customer satisfaction, they aim to exceed expectations and deliver exceptional products and services. As an industry leader, Meridian Bioscience Inc continues to drive advancements in the healthcare sector through their dedication to excellence and integrity.

In which countries and regions is Meridian Bioscience primarily present?

Meridian Bioscience Inc is primarily present in the United States.

What significant milestones has the company Meridian Bioscience achieved?

Meridian Bioscience Inc has achieved several significant milestones throughout its history. One notable accomplishment is the company's development and commercialization of innovative diagnostic test kits for various diseases and healthcare conditions. Furthermore, Meridian Bioscience Inc has consistently expanded its product portfolio, introducing novel technologies to improve healthcare outcomes. The company's dedication to research and development has led to the successful launch of multiple FDA-cleared and CE-marked diagnostic tests. Meridian Bioscience Inc's commitment to quality has enabled it to establish a strong presence in the global diagnostics market.

What is the history and background of the company Meridian Bioscience?

Meridian Bioscience Inc is a leading life science company that develops and markets a broad range of innovative diagnostic products. Founded in 1976, the company has a rich history and a strong background in developing and commercializing diagnostic tests for various infectious diseases. Meridian Bioscience Inc has evolved over the years and has expanded its product portfolio to cater to the needs of laboratories, hospitals, and other healthcare providers worldwide. With a focus on quality, accuracy, and reliability, the company has garnered a reputation for delivering efficient and effective diagnostic solutions. Meridian Bioscience Inc remains committed to advancing healthcare and improving patient outcomes through its cutting-edge diagnostic technologies and dedication to innovation.

Who are the main competitors of Meridian Bioscience in the market?

The main competitors of Meridian Bioscience Inc in the market are companies like Thermo Fisher Scientific, BD (Becton, Dickinson and Company), Quidel Corporation, and Bio-Rad Laboratories. These companies operate in the healthcare and diagnostics industry, offering similar products and services. Meridian Bioscience Inc competes based on factors such as product quality, technological advancements, pricing strategy, and customer satisfaction. While Thermo Fisher Scientific is a well-established player in the market, Meridian Bioscience Inc continues to carve its niche through innovative solutions and a strong customer-centric approach.

In which industries is Meridian Bioscience primarily active?

Meridian Bioscience Inc is primarily active in the healthcare and life sciences industries.

What is the business model of Meridian Bioscience?

The business model of Meridian Bioscience Inc revolves around manufacturing and distributing diagnostic products for the healthcare industry. With a focus on infectious disease testing, the company provides a range of products including molecular and immunoassay tests, as well as reagents and related equipment. Meridian Bioscience Inc aims to develop innovative solutions for quick and accurate diagnosis, helping healthcare professionals worldwide make informed decisions. Through its expertise and continual investment in research and development, the company strives to improve patient outcomes and contribute to the overall public health. Meridian Bioscience Inc's commitment to quality and customer satisfaction is evident in their comprehensive portfolio of diagnostic solutions.

What is the P/E ratio of Meridian Bioscience 2025?

The Meridian Bioscience P/E ratio is 80.28.

What is the P/S ratio of Meridian Bioscience 2025?

The Meridian Bioscience P/S ratio is 5.02.

What is the Quality Investing of Meridian Bioscience?

The Quality Investing for Meridian Bioscience is 7/10.

What is the revenue of Meridian Bioscience 2025?

The expected Meridian Bioscience revenue is 300.53 M USD.

How high is the profit of Meridian Bioscience 2025?

The expected Meridian Bioscience profit is 18.78 M USD.

What is the business model of Meridian Bioscience

Meridian Bioscience Inc is a global company specializing in the development, manufacture, and distribution of diagnostic and testing systems for the rapid and accurate identification of infectious diseases. The company was founded in 1976 and is headquartered in Cincinnati, Ohio. Meridian Bioscience operates several business segments, including diagnostics, OEM, and life science. In the diagnostics segment, the company offers a variety of products for the identification of infectious diseases, including tests for respiratory infections, gastroenteritis, STDs, and Zika virus. Meridian Bioscience's diagnostic products are used in clinical laboratories, hospitals, medical practices, and research laboratories worldwide. The OEM segment of Meridian Bioscience offers customized diagnostic products tailored to the specific requirements of OEM customers. This includes both raw materials and finished products that can be integrated into customers' diagnostic products. The OEM segment of Meridian Bioscience works closely with OEM customers to provide customized, cost-effective, and high-quality products. In the life science segment, Meridian Bioscience offers a wide range of products, including enzymes, antibodies, proteins, buffering solutions, and labeling reagents. These products are used in research and development, diagnostics, and industry. Meridian Bioscience has experienced strong growth in recent years, driven by the introduction of new products, expansion into new markets, and the acquisition of other companies. An example of this is the acquisition of the Bioline Group in 2018, a leading provider of molecular biology products used in research and diagnostics. Meridian Bioscience is committed to developing and manufacturing high-quality products that deliver fast and accurate results. The company works closely with customers and partners to develop innovative products that meet the needs of the healthcare industry. With its wide range of products and commitment to innovation and quality, Meridian Bioscience will continue to play an important role in the diagnostics industry.

What is the Meridian Bioscience dividend?

Meridian Bioscience pays a dividend of 0 USD distributed over payouts per year.

How often does Meridian Bioscience pay dividends?

The dividend cannot currently be calculated for Meridian Bioscience or the company does not pay out a dividend.

What is the Meridian Bioscience ISIN?

The ISIN of Meridian Bioscience is US5895841014.

What is the Meridian Bioscience WKN?

The WKN of Meridian Bioscience is 871583.

What is the Meridian Bioscience ticker?

The ticker of Meridian Bioscience is VIVO.

How much dividend does Meridian Bioscience pay?

Over the past 12 months, Meridian Bioscience paid a dividend of 0.13 USD . This corresponds to a dividend yield of about 0.37 %. For the coming 12 months, Meridian Bioscience is expected to pay a dividend of 0.34 USD.

What is the dividend yield of Meridian Bioscience?

The current dividend yield of Meridian Bioscience is 0.37 %.

When does Meridian Bioscience pay dividends?

Meridian Bioscience pays a quarterly dividend. This is distributed in the months of June, September, December, March.

How secure is the dividend of Meridian Bioscience?

Meridian Bioscience paid dividends every year for the past 3 years.

What is the dividend of Meridian Bioscience?

For the upcoming 12 months, dividends amounting to 0.34 USD are expected. This corresponds to a dividend yield of 1 %.

In which sector is Meridian Bioscience located?

Meridian Bioscience is assigned to the 'Health' sector.

Wann musste ich die Aktien von Meridian Bioscience kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Meridian Bioscience from 2/14/2019 amounting to 0.125 USD, you needed to have the stock in your portfolio before the ex-date on 2/1/2019.

When did Meridian Bioscience pay the last dividend?

The last dividend was paid out on 2/14/2019.

What was the dividend of Meridian Bioscience in the year 2024?

In the year 2024, Meridian Bioscience distributed 0.512 USD as dividends.

In which currency does Meridian Bioscience pay out the dividend?

The dividends of Meridian Bioscience are distributed in USD.

All fundamentals about Meridian Bioscience

Our stock analysis for Meridian Bioscience Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Meridian Bioscience Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.